Weighted Average Number of Shares Outstanding, Basic of Evoke Pharma Inc from 30 Jun 2016 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Evoke Pharma Inc quarterly and annual Weighted Average Number of Shares Outstanding, Basic in shares history and change rate from 30 Jun 2016 to 30 Sep 2025.
  • Evoke Pharma Inc Weighted Average Number of Shares Outstanding, Basic for the quarter ending 30 Sep 2025 was 2,557,408, a 83% increase year-over-year.
  • Evoke Pharma Inc annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 1,905,072, a 584% increase from 2023.
  • Evoke Pharma Inc annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 278,558, a 91% decline from 2022.
  • Evoke Pharma Inc annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 3,143,626, a 17% increase from 2021.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

Evoke Pharma Inc Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 2,557,408 +1,157,526 +83% 01 Jul 2025 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 2,553,174 +1,189,649 +87% 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 2,548,684 +1,791,876 +237% 01 Jan 2025 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q4 2024 1,905,072 +1,626,514 +584% 01 Oct 2024 31 Dec 2024 10-K 13 Mar 2025 2024 FY
Q3 2024 1,399,882 +1,121,324 +403% 01 Jul 2024 30 Sep 2024 10-Q 13 Nov 2025 2025 Q3
Q2 2024 1,363,525 +1,084,967 +389% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025 2025 Q2
Q1 2024 756,808 -2,586,262 -77% 01 Jan 2024 31 Mar 2024 10-Q 13 May 2025 2025 Q1
Q4 2023 278,558 -2,865,068 -91% 01 Oct 2023 31 Dec 2023 10-K 13 Mar 2025 2024 FY
Q3 2023 278,558 -3,064,512 -92% 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024 2024 Q3
Q2 2023 278,558 -2,878,367 -91% 01 Apr 2023 30 Jun 2023 10-Q 13 Aug 2024 2024 Q2
Q1 2023 3,343,070 +611,630 +22% 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024 2024 Q1
Q4 2022 3,143,626 01 Oct 2022 31 Dec 2022 10-K/A 14 May 2024 2023 FY
Q3 2022 3,343,070 +631,199 +23% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023 2023 Q3
Q2 2022 3,156,925 +458,092 +17% 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023 2023 Q2
Q1 2022 2,731,440 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1
Q3 2021 2,711,871 01 Jul 2021 30 Sep 2021 10-Q 09 Nov 2022 2022 Q3
Q2 2021 2,698,833 01 Apr 2021 30 Jun 2021 10-Q 10 Aug 2022 2022 Q2
Q3 2018 17,129,649 +1,778,354 +12% 01 Jul 2018 30 Sep 2018 10-Q 13 Nov 2018 2018 Q3
Q2 2018 16,425,468 +1,082,143 +7.1% 01 Apr 2018 30 Jun 2018 10-Q 09 Aug 2018 2018 Q2
Q4 2017 15,368,610 01 Oct 2017 31 Dec 2017 10-K 06 Mar 2019 2018 FY
Q3 2017 15,351,295 +4,736,603 +45% 01 Jul 2017 30 Sep 2017 10-K 06 Mar 2019 2018 FY
Q2 2017 15,343,325 +8,125,748 +113% 01 Apr 2017 30 Jun 2017 10-K 06 Mar 2019 2018 FY
Q1 2017 13,528,311 01 Jan 2017 31 Mar 2017 10-K 06 Mar 2019 2018 FY
Q3 2016 10,614,692 01 Jul 2016 30 Sep 2016 10-Q 14 Nov 2017 2017 Q3
Q2 2016 7,217,577 01 Apr 2016 30 Jun 2016 10-Q 14 Aug 2017 2017 Q2

Evoke Pharma Inc Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 1,905,072 +1,626,514 +584% 01 Jan 2024 31 Dec 2024 10-K 13 Mar 2025 2024 FY
2023 278,558 -2,865,068 -91% 01 Jan 2023 31 Dec 2023 10-K 13 Mar 2025 2024 FY
2022 3,143,626 +461,481 +17% 01 Jan 2022 31 Dec 2022 10-K/A 14 May 2024 2023 FY
2021 2,682,145 01 Jan 2021 31 Dec 2021 10-K 21 Mar 2023 2022 FY
2018 16,602,422 +1,704,537 +11% 01 Jan 2018 31 Dec 2018 10-K 06 Mar 2019 2018 FY
2017 14,897,885 +5,559,817 +60% 01 Jan 2017 31 Dec 2017 10-K 06 Mar 2019 2018 FY
2016 9,338,068 01 Jan 2016 31 Dec 2016 10-K 07 Mar 2018 2017 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.